Novo Nordisk hikes its 2026 outlook, but investors focus more on quarterly sales of the Danish pharma giant's Wegovy weight loss pill, which came in slightly lower than expected. CEO Mike Doustdar ...

Jefferies' Mahesh Nandurkar says extreme underweight positioning has left India's IT sector ripe for a tactical rebound.

Josh Young from Bison Interests discusses Saudi Aramco's latest earnings report and highlights supply risks due to ...

Steve Westly, founder and managing partner at The Westly Group and a former Tesla board member discusses SpaceX, the ...

Justina Chiu, CEO of Hong Kong-based retail property operator Fortune REIT, discusses the REIT's earnings recovery, with ...

CEO Elon Musk said SpaceX would hit $1 trillion in annual revenue in 2030 versus a previous forecast of 2031 as he looked to ...

DBS Bank's Taimur Baig says that instability in the Yen will create implications globally as a widely traded currency. He highlights the importance of Bank of Japan and Japan's finance ministry ...

Sanjay Mathur, chief economist for Southeast Asia and India at ANZ discusses the latest Reserve Bank of India decision, where the repo rate was left unchanged.

Johns Hopkins SAIS' Samm Sacks discusses why Chinese AI models could become increasingly commoditised as Beijing shifts its focus to the application layer and why exempting open-source models from the ...

Santosh Mehrotra from Institute of Education, Higher School of Economics, Moscow says jobs growth at India's IT services ...

Adel Abdel Ghafar from the Australian Strategic Policy Institute says Iran wants a guarantee that the U.S. will not continue or expand its conflict with Tehran, and that it has shown it is able to ...

Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.